Clinical Trial Update: Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass [NA]

View source ↗

Summary

ClinicalTrials.gov update notes a completed study comparing 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solutions for cardiopulmonary bypass in mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Disease

Drugs mentioned

• Human Albumin 5% priming solution (Human serum albumin 5%)
• Hydroxyethyl Starch 130/0.4 (6%) priming solution (Hydroxyethyl starch 130/0.4)

Snippet

Sponsor: Yonsei University | Conditions: Mitral Valvular Heart Disease | NA | Status: COMPLETED